Subcutaneous injection and/or topical application of sodium butyrate attenuate the hapten-induced AD in mice by recruiting Tregs and inducing the production of the anti-inflammatory cytokine, IL-10 [181]. This evidence concerns the gene IL10 and Alzheimer disease.